Micropaque Suspensie (Barium Sulfate)

Barium sulfate, the active ingredient in Micropaque Suspensie, is a contrast media presented as a suspension for oral and rectal use. It provides radiopaque contrast for imaging of the gastrointestinal tract in patients undergoing diagnostic procedures.

GNH USA supplies Micropaque Suspensie as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Micropaque Suspensie, a barium sulfate‑based contrast agent, is used for radiographic evaluation of the gastrointestinal tract.

- Esophageal barium study: visualizes esophageal anatomy and motility. - Gastric barium study: delineates stomach contour and detects lesions. - Intestinal barium study: outlines small and large bowel for identification of abnormalities.

Adverse reactions to Micropaque Suspensie are generally uncommon but may occur following oral or rectal administration.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal cramping: transient discomfort in the abdomen. - Constipation: temporary difficulty passing stool. - Diarrhea: loose stools occurring shortly after administration.

Serious or Rare Side Effects: - Bowel obstruction: rare blockage requiring medical attention. - Allergic reaction: hives, swelling, or anaphylaxis. - Peritonitis: inflammation of the abdominal lining in rare cases.

Before using Micropaque Suspensie, consider the following precautions to ensure safe and effective imaging.

- Contraindication: avoid in patients with known bowel perforation. - Allergy assessment: screen for hypersensitivity to barium sulfate. - Recent surgery: postpone if recent gastrointestinal surgery has been performed. - Hydration: ensure adequate fluid intake before and after the study. - Pregnancy: use only if benefits outweigh potential risks, as safety is not established. - Store at ambient temperature: keep below 25°C, retain original container, protect from moisture.

Micropaque Suspensie may interact with certain medications or substances that affect gastrointestinal function or imaging interpretation.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may reduce barium coating and affect image quality. - Oral iodine‑based contrast agents: simultaneous use can cause image artifacts.

Moderate Interactions (Monitor Closely): - Laxatives: may alter transit time and distribution of barium. - Motility agents (e.g., metoclopramide): can affect barium movement through the GI tract. - Iron supplements: can cause discoloration of images if taken close to the study.